$MNKD
MANNKIND CORP

2020 Q1 Form 10-Q Financial Statement

#000156459020021910 Filed on May 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $16.24M $17.45M
YoY Change -6.95% 403.55%
Cost Of Revenue $4.164M $4.020M
YoY Change 3.58% 0.3%
Gross Profit $12.07M $13.43M
YoY Change -10.11% -2572.93%
Gross Profit Margin 74.35% 76.96%
Selling, General & Admin $14.35M $25.67M
YoY Change -44.1% 24.52%
% of Gross Profit 118.88% 191.19%
Research & Development $1.755M $1.667M
YoY Change 5.28% -36.95%
% of Gross Profit 14.54% 12.41%
Depreciation & Amortization $443.0K $367.0K
YoY Change 20.71% -8.25%
% of Gross Profit 3.67% 2.73%
Operating Expenses $16.11M $27.34M
YoY Change -41.09% 17.53%
Operating Profit -$4.034M -$13.51M
YoY Change -70.15% -49.55%
Interest Expense -$400.0K $500.0K
YoY Change -180.0% -108.62%
% of Operating Profit
Other Income/Expense, Net -$2.201M -$1.369M
YoY Change 60.77% -61.93%
Pretax Income -$9.322M -$14.88M
YoY Change -37.36% -51.02%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$9.322M -$14.88M
YoY Change -37.36% -51.02%
Net Earnings / Revenue -57.42% -85.3%
Basic Earnings Per Share
Diluted Earnings Per Share -$43.76K -$79.51K
COMMON SHARES
Basic Shares Outstanding 212.3M 187.3M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.90M $59.30M
YoY Change -34.4% 122.1%
Cash & Equivalents $39.18M $35.06M
Short-Term Investments $0.00 $24.80M
Other Short-Term Assets $2.200M $2.900M
YoY Change -24.14% 0.0%
Inventory $3.231M $3.700M
Prepaid Expenses
Receivables $5.032M $3.800M
Other Receivables $0.00 $0.00
Total Short-Term Assets $49.35M $69.70M
YoY Change -29.2% 98.98%
LONG-TERM ASSETS
Property, Plant & Equipment $26.52M $31.30M
YoY Change -15.28% 18.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.347M
YoY Change
Total Long-Term Assets $30.86M $31.30M
YoY Change -1.39% 16.58%
TOTAL ASSETS
Total Short-Term Assets $49.35M $69.70M
Total Long-Term Assets $30.86M $31.30M
Total Assets $80.21M $101.0M
YoY Change -20.58% 63.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.731M $7.000M
YoY Change -3.84% 40.68%
Accrued Expenses $18.33M $15.40M
YoY Change 19.0% -3.33%
Deferred Revenue $30.84M $32.38M
YoY Change -4.77%
Short-Term Debt $5.100M $11.40M
YoY Change -55.26% -73.91%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $68.25M $77.90M
YoY Change -12.39% -3.43%
LONG-TERM LIABILITIES
Long-Term Debt $113.9M $91.10M
YoY Change 25.03% -5.69%
Other Long-Term Liabilities $96.10M $120.0M
YoY Change -19.92% 11.32%
Total Long-Term Liabilities $210.0M $211.1M
YoY Change -0.52% 3.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $68.25M $77.90M
Total Long-Term Liabilities $210.0M $211.1M
Total Liabilities $278.3M $289.0M
YoY Change -3.72% 1.37%
SHAREHOLDERS EQUITY
Retained Earnings -$3.001B
YoY Change
Common Stock $2.803B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$198.1M -$188.0M
YoY Change
Total Liabilities & Shareholders Equity $80.21M $101.0M
YoY Change -20.58% 63.23%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$9.322M -$14.88M
YoY Change -37.36% -51.02%
Depreciation, Depletion And Amortization $443.0K $367.0K
YoY Change 20.71% -8.25%
Cash From Operating Activities -$11.22M -$11.60M
YoY Change -3.26% -46.43%
INVESTING ACTIVITIES
Capital Expenditures $150.0K $269.0K
YoY Change -44.24%
Acquisitions
YoY Change
Other Investing Activities $20.00M -$24.76M
YoY Change -180.78%
Cash From Investing Activities $19.85M -$25.03M
YoY Change -179.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 331.0K 3.000K
YoY Change 10933.33% -99.43%
NET CHANGE
Cash From Operating Activities -11.22M -11.60M
Cash From Investing Activities 19.85M -25.03M
Cash From Financing Activities 331.0K 3.000K
Net Change In Cash 8.962M -36.63M
YoY Change -124.47% 73.41%
FREE CASH FLOW
Cash From Operating Activities -$11.22M -$11.60M
Capital Expenditures $150.0K $269.0K
Free Cash Flow -$11.37M -$11.87M
YoY Change -4.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-190526000
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5000000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4155000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26778000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2889000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
60757000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3513000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4164000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4020000
CY2020Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1521000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
1796000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1071000
CY2020Q1 mnkd Interest Expense Incurred On Promissory Notes
InterestExpenseIncurredOnPromissoryNotes
1259000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2019Q4 mnkd Promissory Notes Noncurrent
PromissoryNotesNoncurrent
70020000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16235000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17448000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2201000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9322000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-9322000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
212467000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-19000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9341000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14883000
CY2020Q1 mnkd Promissory Notes Noncurrent
PromissoryNotesNoncurrent
70022000
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5028000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Notes Payable Current
NotesPayableCurrent
5101000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15904000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32503000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6731000
CY2020Q1 us-gaap Assets
Assets
80212000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
65618000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18326000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6190000
CY2020Q1 mnkd Purchase Obligation Current
PurchaseObligationCurrent
7250000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4789000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30840000
CY2019Q4 mnkd Purchase Obligation Current
PurchaseObligationCurrent
7394000
CY2019Q4 us-gaap Assets
Assets
93725000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4347000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
68248000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1901000
CY2020Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1772000
CY2020Q1 mnkd Purchase Obligation Noncurrent
PurchaseObligationNoncurrent
82987000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26517000
CY2020Q1 us-gaap Inventory Net
InventoryNet
3231000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2155000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 mnkd Purchase Obligation Noncurrent
PurchaseObligationNoncurrent
84639000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2514000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
49348000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5032000
CY2020Q1 mnkd Milestone Rights Liabilities Noncurrent
MilestoneRightsLiabilitiesNoncurrent
5926000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2991903000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
211787573
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213137684
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3001225000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
211787573
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-198050000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80212000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93725000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1369000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14883000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-14883000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
187434000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
317000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
999000
CY2020Q1 mnkd Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
-317000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
2131000
CY2020Q1 mnkd Accrued Interest Noncurrent
AccruedInterestNoncurrent
3259000
CY2019Q4 mnkd Accrued Interest Noncurrent
AccruedInterestNoncurrent
2002000
CY2020Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213137684
CY2020Q1 us-gaap Liabilities
Liabilities
278262000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2801044000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
280000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
280000000
CY2020Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1755000
CY2019Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1667000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14350000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25673000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-175082000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1599000
CY2019Q1 mnkd Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
2000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
105000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-188004000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
318000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1128000
CY2020Q1 mnkd Stock Issued During Period Value Debt Interest Payment
StockIssuedDuringPeriodValueDebtInterestPayment
144000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
16000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-9322000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-14883000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1128000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
999000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
538000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
367000
CY2020Q1 mnkd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
282000
CY2019Q1 mnkd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
395000
CY2020Q1 mnkd Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
1257000
CY2019Q1 mnkd Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
1134000
CY2020Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
496000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-19000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-104000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1661000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-258000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-428000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
123000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-988000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-164000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-40000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
340000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1942000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1880000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2336000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-8235000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
686000
CY2020Q1 mnkd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-724000
CY2019Q1 mnkd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-395000
CY2019Q1 mnkd Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
-1963000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11219000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11597000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
150000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
269000
CY2019Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
24764000
CY2020Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
20000000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19850000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25033000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
325000
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
331000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8962000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36627000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30222000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
71684000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39184000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35057000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
885000
CY2020Q1 mnkd Common Stock Issuance To Settle Employee Stock Purchase Plan Liability
CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability
318000
CY2019Q1 mnkd Common Stock Issuance To Settle Employee Stock Purchase Plan Liability
CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability
317000
CY2020Q1 mnkd Payment Of Interest On Senior Convertible Notes Through Common Stock Issuance
PaymentOfInterestOnSeniorConvertibleNotesThroughCommonStockIssuance
144000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
32000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
246000
CY2019Q1 mnkd Addition Of Right Of Use Assets
AdditionOfRightOfUseAssets
5192000
CY2019Q1 mnkd Payment Of Interest On Senior Convertible Notes Through Common Stock Issuance
PaymentOfInterestOnSeniorConvertibleNotesThroughCommonStockIssuance
534000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Statement Estimates<font style="font-style:normal;"> &#8212; The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process and the threat of the COVID-19 pandemic has increased the level of judgment used by management in developing these estimates and assumptions. The COVID-19 pandemic continues to rapidly evolve and the ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying condensed consolidated financial statements. The more significant estimates include revenue recognition and gross-to-net adjustments, assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, milestone rights liability, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets. </font></p>
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk<font style="font-style:normal;"> &#8212; Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and short-term investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market accounts and U.S. Treasury securities, which are regularly monitored by management. </font> </p>
CY2020Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
120300000
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
0
CY2020Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
38800556
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
78540210
CY2020Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8393000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
409000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
6925000
CY2020Q1 mnkd Wholesaler Distribution Fees And Prompt Pay Discounts
WholesalerDistributionFeesAndPromptPayDiscounts
1458000
CY2019Q4 mnkd Wholesaler Distribution Fees And Prompt Pay Discounts
WholesalerDistributionFeesAndPromptPayDiscounts
1767000
CY2020Q1 mnkd Reserve For Returns
ReserveForReturns
1903000
CY2019Q4 mnkd Reserve For Returns
ReserveForReturns
1645000
CY2020Q1 mnkd Number Of Wholesale Distributors
NumberOfWholesaleDistributors
3
CY2020Q1 mnkd Percentage Of Accounts Receivable From Major Customers
PercentageOfAccountsReceivableFromMajorCustomers
0.91
CY2020Q1 mnkd Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
0.92
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1643000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1751000
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
495000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1432000
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1093000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
972000
CY2019Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
122285000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
122142000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95768000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95364000
CY2020Q1 us-gaap Depreciation
Depreciation
443000
CY2019Q1 us-gaap Depreciation
Depreciation
367000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10217000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8835000
CY2020Q1 mnkd Customer Discounts And Allowances
CustomerDiscountsAndAllowances
3534000
CY2019Q4 mnkd Customer Discounts And Allowances
CustomerDiscountsAndAllowances
3162000
CY2020Q1 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1415000
CY2019Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1433000
CY2020Q1 mnkd Milestone Rights Liabilities Current
MilestoneRightsLiabilitiesCurrent
1337000
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
314000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
620000
CY2020Q1 mnkd Sales And Marketing Related Expenses Accrued
SalesAndMarketingRelatedExpensesAccrued
309000
CY2019Q4 mnkd Sales And Marketing Related Expenses Accrued
SalesAndMarketingRelatedExpensesAccrued
147000
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
337000
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
863000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1298000
CY2020Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
70022000
CY2019Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
70020000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
119016000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
118899000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
5262000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4444000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
13333000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
13333000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
83940000
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
120312000
CY2020Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
450000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
846000
CY2020Q1 mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
89000
CY2019Q1 mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
72000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-27000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-22000
CY2019Q1 mnkd Amortization Of Debt Premium
AmortizationOfDebtPremium
-95000
CY2020Q1 mnkd Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
7300000
CY2019Q4 mnkd Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
7300000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
500000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
100000
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2020Q1 mnkd Payment For Milestone Rights Liabilities
PaymentForMilestoneRightsLiabilities
5000000
CY2020Q1 mnkd Fair Value Of Debt Instruments To Related Party Description
FairValueOfDebtInstrumentsToRelatedPartyDescription
The fair value measurement of debt instruments is based on a discounted cash flow model and is sensitive to the change in yield (Level 3 in the fair value hierarchy
CY2020Q1 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
95700000
CY2019Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
110600000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1128000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
999000
CY2019Q3 mnkd Purchase Obligation Extended Term
PurchaseObligationExtendedTerm
2026
CY2020Q1 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
6600000
CY2020Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
6600000
CY2020Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
8500000
CY2020Q1 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
10800000
CY2020Q1 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
14600000
CY2020Q1 mnkd Purchase Obligation Due In Sixth Year
PurchaseObligationDueInSixthYear
15500000
CY2020Q1 mnkd Purchase Obligation Due In Seventh Year
PurchaseObligationDueInSeventhYear
19400000
CY2020Q1 mnkd Long Term Purchase Commitment Expiration Date
LongTermPurchaseCommitmentExpirationDate
2026-12-31
CY2020Q1 mnkd Longterm Purchase Commitment Renewal Time Period
LongtermPurchaseCommitmentRenewalTimePeriod
P2Y
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
400000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
100000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
500000

Files In Submission

Name View Source Status
0001564590-20-021910-index-headers.html Edgar Link pending
0001564590-20-021910-index.html Edgar Link pending
0001564590-20-021910.txt Edgar Link pending
0001564590-20-021910-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mnkd-10q_20200331.htm Edgar Link pending
mnkd-20200331.xml Edgar Link completed
mnkd-20200331.xsd Edgar Link pending
mnkd-20200331_cal.xml Edgar Link unprocessable
mnkd-20200331_def.xml Edgar Link unprocessable
mnkd-20200331_lab.xml Edgar Link unprocessable
mnkd-20200331_pre.xml Edgar Link unprocessable
mnkd-ex311_7.htm Edgar Link pending
mnkd-ex312_6.htm Edgar Link pending
mnkd-ex321_8.htm Edgar Link pending
mnkd-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending